Skip to main content
. 2017 Apr 20;8(42):71489–71499. doi: 10.18632/oncotarget.17288

Table 1. Primers used in this study.

Name Sequences (5′ -> 3′)
CD44 Forward AGAAGGTGTGGGCAGAAGAA
CD44 Reverse AAATGCACCATTTCCTGAGA
CD133 Forward GCATTGGCATCTTCTATGGTT
CD133 Reverse CGCCTTGTCCTTGGTAGTGT
cMet Forward GGTTGTGGTTTCTCGATCAGG
cMet Reverse TTCGTGATCTTCTTCCCAGTGA
β-catenin Forward AAAATGGCAGTGCGTTTAG
β-catenin Reverse TTTGAAGGCAGTCTGTCGTA
Slug Forward CTGGGCTGGCCAAACATAAG
Slug Reverse CCTTGTCACAGTATTTACAGCTGAAG
Twist Forward GCAGGACGTGTCCAGCTC
Twist Reverse CTGGCTCTTCCTCGCTGTT
Snail Forward TTCTCTAGGCCCTGGCTGC
Snail Reverse TACTTCTTGACATCTGAGTGGGTCTG
β-Actin 184 Forward AGAGCTACGAGCTGCCTGAC
β-Actin 184 Reverse AGCACTGTGTTGGCGTACAG